Author pages are created from data sourced from our academic publisher partnerships and public sources.
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.
PURPOSE To evaluate Ozurdex (dexamethasone intravitreal implant [DEX implant]; Allergan, Inc, Irvine, CA) 0.7 mg combined with laser photocoagulation compared with laser alone for treatment of… Expand
Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery.
- E. Donnenfeld, L. Nichamin, +9 authors R. Schiffman
- American journal of ophthalmology
- 1 March 2011
PURPOSE To evaluate the efficacy and safety of twice-daily, preservative-free ketorolac 0.45% (Acuvail; Allergan, Inc, Irvine, California, USA) administration for treatment of inflammation and pain… Expand
EFFICACY AND SAFETY OF TWO OR MORE DEXAMETHASONE INTRAVITREAL IMPLANT INJECTIONS FOR TREATMENT OF MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION (SHASTA STUDY)
Purpose: To evaluate the efficacy, safety, and reinjection interval of dexamethasone intravitreal implant (DEX implant) in branch retinal vein occlusion and central retinal vein occlusion patients… Expand
Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension
- G. Schwartz, D. Hollander, J. M. Williams
- Current medical research and opinion
- 16 October 2013
Abstract Objective: To evaluate eye drop administration by patients at multiple visits in the setting of a randomized controlled trial. Study design and methods: Patients with glaucoma or ocular… Expand
Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry Eye.
PURPOSE To investigate changes in signs, symptoms, and tear cytokines following punctal plug occlusion in patients with dry eye. METHODS A single-center study was conducted at Singapore Eye… Expand
Drug-induced corneal complications
Purpose of review To review the common corneal manifestations of systemic medications in order to describe the characteristic clinical features associated with particular systemic drugs, the… Expand
Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
OBJECTIVE To evaluate the efficacy and tolerability of brimonidine purite 0.1% in comparison to brinzolamide 1% when used as adjunctive therapy to latanoprost 0.005% in patients with glaucoma or… Expand
Evaluating teaching methods of cataract surgery: Validation of an evaluation tool for assessing surgical technique of capsulorhexis
- R. Smith, C. McCannel, +6 authors B. Mondino
- Journal of cataract and refractive surgery
- 1 May 2012
PURPOSE: To develop and assess the validity of an evaluation tool to quantitatively assess the capsulorhexis portion of cataract surgery performed by residents. SETTING: University of California at… Expand
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
Purpose To evaluate the efficacy, safety, and injection frequency of vascular endothelial growth factor (VEGF) inhibitors as used in clinical practice for the treatment of diabetic macular edema.… Expand
Genotype and phenotype correlations in congenital glaucoma: CYP1B1 mutations, goniodysgenesis, and clinical characteristics.
- D. Hollander, M. Sarfarazi, I. Stoilov, I. Wood, D. Fredrick, J. Alvarado
- Biology, Medicine
- American journal of ophthalmology
- 1 December 2006
PURPOSE To determine whether there is a correlation among mutations in the cytochrome P4501B1 gene (CYP1B1), the degree of angle dysgenesis observed histologically, and disease severity in congenital… Expand